7th Bladder Cancer Translational Research Meeting
Early bird registration for the 7th Bladder Cancer Translational Research Meeting is now open! Join the University of Birmingham Bladder Cancer Research Centre and the Kings College London & Guys […]
MHRA grants marketing authorisation for BALVERSA®▼ (erdafitinib) as monotherapy for the treatment of adults with unresectable or metastatic urothelial carcinoma (UC) harbouring susceptible FGFR3 genetic alterations who have previously received at least one line of therapy containing a PD-1 or PD-L1 inhibitor in the unresectable or metastatic treatment setting
10,500 people in the UK are diagnosed with bladder cancer every year[1] Around 20 percent of people with advanced or metastatic bladder cancer have fibroblast growth factor receptor 3 (FGFR3) […]
Experimental compound kills cancer and spares immune cells
Researchers in the US have identified a compound that selectively eliminates cancer cells while sparing immune cells in a form of cell death known as ferroptosis. The findings, published in Science […]
UCLH to focus on trials of personalised cancer treatments
Among the many cancer clinical trials opening each year at University College London Hospitals, this year will see a focus on trials of personalised cancer treatments based on precision immunotherapies. […]
6th Bladder Cancer Translational Research Meeting
The Bladder Cancer Research Centre (University of Birmingham) and the Translational Oncology & Urology Research (TOUR) team (King’s College London and Guy’s Hospital) are organising their 6th Bladder Cancer Translational […]
Researchers identify immune cell that helps kill bladder cancer tumours
Researchers in America have made two important discoveries about the mechanism by which bladder cancer cells foil attacks from the immune system. The study by Mount Sinai researchers, published in Cancer […]
Study to evaluate bladder cancer patients’ response to BCG immunotherapy
Two leading organisations have begun discussions about starting a clinical study to evaluate the response of bladder cancer patients to BCG immunotherapy. Ludwig Enterprises, which is an innovator of genetic […]
New combination treatment for bladder cancer revealed
A promising treatment for bladder cancer has been revealed this week at The European Society for Medical Oncology (ESMO) Congress 2022. Researchers from Memorial Sloan Kettering Cancer Center (MSK) presented […]
Possible treatment identified for a quarter of bladder cancers
Researchers at the University of Alabama at Birmingham now report a potential treatment for a quarter of bladder cancers. Their discovery, published in the journal JCI Insight, comes from mechanistic insights of gene […]
Treatments that suppress androgens may help fight bladder cancer
Male sex hormones interfere with the body’s ability to fight bladder cancer, likely explaining why males experience higher cancer rates and more deadly disease, according to a new study co-led […]
